What Is BDNF? Benefits, Research & Safety
A critical growth factor for brain health, neuroplasticity, and neuronal survival, with implications for depression, memory, and neurodegenerative diseases.
UK summary: Endogenous neurotrophin essential for brain plasticity. Not a medicine; the molecule is too large and unstable to be useful as a therapeutic. This entry is educational background.
Quick Facts
Overview
BDNF — evidence and risk at a glance
Twenty standard modules scored against the Peptide Authority evidence grading methodology. Missing modules indicate the field has not yet been characterised editorially — treat absences as uncertainty rather than reassurance.
01Evidence snapshot
Endogenous neurotrophin essential for brain plasticity. Not a medicine; the molecule is too large and unstable to be useful as a therapeutic. This entry is educational background.
02Human evidence grade
03Preclinical evidence grade
04Regulatory status
- UK: BDNF is not a therapeutic agent but a research biomarker and target.
- EU: Same—research focus rather than approved medication.
- Notes: BDNF itself is not administered therapeutically. Research focuses on enhancing endogenous BDNF through lifestyle interventions or developing small molecules that mimic its effects. BDNF levels are increasingly used as biomarkers in research and clinical settings.
05Approved medical uses
None in the UK or EU as a finished medicine. (Or: not yet documented; treat as absence rather than approval.)
06Unapproved / promotional claims
- BDNF supplements raise brain BDNF.
- BDNF peptide injections treat depression and Alzheimer's.
- Direct BDNF administration enhances learning and memory.
07Common internet claims
- Marketed as a supplement to boost BDNF for depression / cognition.
- Sold by some online retailers as a research-only injection.
- Promoted in nootropic stacks as a brain-derived growth factor.
08Claim vs evidence
| Claim | Evidence | Human evidence? | Regulatory concern | Safer wording |
|---|---|---|---|---|
| “BDNF supplements raise your brain BDNF levels” | E | No | High | BDNF cannot cross the blood-brain barrier; oral BDNF supplements have no rational mechanism. Exercise, sleep, and certain medications do affect BDNF levels indirectly. |
09Safety uncertainty score
Limited human safety data; meaningful uncertainty about rare or long-term effects.
10Known adverse signals
- Native BDNF is too large and unstable to cross the blood-brain barrier; exogenous routes are pharmacologically problematic.
- Injectable claims are not backed by any clinical trial or safety data.
- Theoretical risk of disrupting endogenous neurotrophin signalling.
11Drug-interaction uncertainty
Interaction picture sparse; meaningful uncertainty when combined with other medicines.
12Anti-doping status
13UK legal position
BDNF is not a therapeutic agent but a research biomarker and target.
14EU legal position
Same—research focus rather than approved medication.
15What this page cannot tell you
- Whether any 'BDNF supplement' actually raises BDNF in your brain (mechanistically implausible).
- Whether any injectable BDNF product contains BDNF protein at any concentration.
- Long-term effects of exogenous BDNF signalling on neural circuits.
16Last reviewed
17Citation quality score
18Research gaps
- Delivery problem (blood-brain barrier) prevents BDNF being developed as a therapeutic itself.
- TrkB-receptor small-molecule agonists are under investigation as a more practical route.
19Safer alternatives / established care pathways
- Regular aerobic exercise — the strongest evidence-based intervention that raises endogenous BDNF.
- Adequate sleep, social engagement, learning new skills — all support BDNF expression.
- Licensed antidepressants for depression (they upregulate BDNF as part of their mechanism).
- Memory clinic referral if cognitive decline is the concern.
20Doctor discussion prompts
Questions to ask a qualified clinician
These are starter questions you can adapt for a GP, specialist, pharmacist, or anti-doping advisor. The aim is to help you have a better-informed conversation — not to replace one.
- What evidence-based interventions affect BDNF (exercise, sleep, licensed medicines)?
Discovery & History
Mechanism of Action
Researched Benefits
Based on preclinical and clinical research findings:
- 1Essential for learning and memory formation
- 2Supports neuronal survival and neurogenesis
- 3Promotes synaptic plasticity
- 4Potential target for depression treatment
- 5May protect against neurodegenerative diseases
- 6Mediates beneficial effects of exercise on the brain
- 7Biomarker for neurological and psychiatric conditions
Claim vs Evidence
How popular claims about BDNF stack up against the current research, graded using our public evidence grading methodology.
| Claim | Evidence | Human evidence? | Regulatory concern | Safer wording |
|---|---|---|---|---|
| “BDNF supplements raise your brain BDNF levels” | E | No | High | BDNF cannot cross the blood-brain barrier; oral BDNF supplements have no rational mechanism. Exercise, sleep, and certain medications do affect BDNF levels indirectly. |
Theoretical Dosing & Protocols
| Theoretical Dosage | Not applicable for direct administration |
| Frequency | N/A |
| Duration | N/A |
| Notes | BDNF does not cross the blood-brain barrier effectively, limiting direct administration. Research focuses on increasing endogenous BDNF through exercise, diet, certain medications, and developing BDNF-mimetic compounds. |
Administration Routes
Routes studied in research settings (educational only):
- Direct administration not practical (does not cross blood-brain barrier)
- Research focuses on indirect enhancement strategies
- Intrathecal/intracerebroventricular routes used only in animal research
| Half-Life | Stability |
|---|---|
| Short in circulation; locally produced and acts in paracrine/autocrine fashion | Requires careful handling in research settings |
Safety Profile & Known Risks
Commonly Reported Side Effects
- Not directly administered therapeutically
Rare Risks & Concerns
- Excessive BDNF has been linked to epilepsy in animal models
- Chronic pain sensitization (peripheral BDNF)
- Theoretical concerns about promoting tumour growth
Contraindications
- Direct BDNF administration is not a current therapeutic approach
UK & EU Regulatory Context
🇬🇧 United Kingdom
BDNF is not a therapeutic agent but a research biomarker and target.
🇪🇺 European Union
Same—research focus rather than approved medication.
Clinical Studies Summary
Blood levels of brain-derived neurotrophic factor (BDNF) in psoriasis: a systematic review and meta-analysis.
This study found a significant reduction in BDNF levels in psoriasis patients, suggesting a potential link between BDNF dysregulation and the pathophysiology of psoriasis. Understanding the role of BDNF in these conditions may inform future research and therapeutic strategies for patients suffering from both.
Association Between Irisin Level and Cognitive Function: A Systematic Review and Meta-Analysis.
This study implied that irisin has a positive effect on cognitive function, and the mechanism may be associated with promoting the expression of BDNF.
Peripheral neurotrophin levels during controlled crack/cocaine abstinence: a systematic review and meta-analysis.
Further improved methods are suggested, and a potential BDNF augmentation hypothesis is proposed that, if true, would help to understand initial abstinence as a re-adaptation period influenced by neurotrophins such as the BDNF.
Brain-derived neurotrophic factor levels across psychiatric disorders: A systemic review and network meta-analysis.
08]). In conclusion, abnormal BDNF levels have been found in psychiatric disorders, and the changes in peripheral BDNF levels in patients with psychiatric disorders were reconfirmed in this study, which suggests BDNF exhibits promising clinical utility and may hold diagnostic value in distinguishing between MDD and BD.
Effect of cannabis use on blood levels of brain-derived neurotrophic factor (BDNF) and nerve growth factor (NGF): A systematic review and meta-analysis.
This systematic review highlights the need for further research to elucidate the relationship between cannabis use and these neurotrophic factors. A better understanding of these associations can contribute to our knowledge of the neurobiological effects of cannabis and inform potential implications for mental health, cognitive function, and neurodegenerative disorders.
Brain-derived neurotrophic factor (BDNF) levels in panic disorder: A systematic review and meta-analysis.
This systematic review and meta-analysis provide evidence of lower BDNF protein levels in individuals diagnosed with panic disorder compared to healthy controls. The findings suggest a potential role for BDNF dysregulation in the pathophysiology of panic disorder. Further research is warranted to elucidate the underlying mechanisms and potential therapeutic implications.
Registered Trials & Regulatory Status
15 of 16 completed trials have never posted results. Unreported trials are not neutral: results that go unpublished are more often negative ones.
The Role of Urinary RhoA, NGF, and BDNF Levels in Overactive Bladder and Vitamin D Deficiency
Status: Not Yet Recruiting · 52 participants · Tarik Emre Sener
Conditions: Overactive Bladder, Vitamin D Deficiency
Study on the Mechanism of Pei Tu Ning Feng Tang in Alleviating Tourette Syndrome Via Functional Near-Infrared Spectroscopy (fNIRS) and the DA-MAPK-BDNF Pathway
Status: Not Yet Recruiting · 60 participants · Dongdong Qin
Conditions: Tourette Syndrome in Children
Investigating the Evolutionary Impact of Metabolic Flexibility on Physical Activity-Dependent BDNF and Cognition: Insights From the Val66Met Polymorphism
Status: Not Yet Recruiting · 50 participants · University of Southern California
Conditions: Cognition, BDNF
Effects of Different Types of Exercise on BDNF and Cognitive Performance (Exercise-BDNF)
Status: Completed · 12 participants · Aksaray University Training and Research Hospital
Conditions: Exercise Training, BDNF, Cognitive Functions
Effect of Isometric Neck Exercises on Cervicogenic Headache Symptoms, Cortisol and BDNF Levels Among Smart Phone Users
Status: Completed · 44 participants · Khyber Medical University Peshawar
Conditions: Cervicogenic Headache, Sleep Disturbance, Stress
Preoperative Study of the Correlation Between BDNF-TrkB Signaling Pathway Expression Levels in Cerebrospinal Fluid and Blood and Postpartum Depression
Status: Completed · 200 participants · The First People's Hospital of Lianyungang
Conditions: Postpartum Depression (PPD)
Curcumin and EGCG Supplementation to Improve Serum BDNF and Mood Disturbance
Status: Recruiting · 64 participants · Auburn University
Conditions: Mood Disturbance
THE EFFECTS OF GAMBIR CATECHIN (UNCARIA GAMBIR ROXB) SUPPLEMENTATION ON COGNITIVE FUNCTION, EXPRESSION OF APP, MAPT, BDNF, IL-10, TGF-Β GENES, AND PLASMA MDA LEVELS IN THE ELDERLY.
Status: Completed · 64 participants · Rahmi Novita Yusuf
Conditions: Elderly Individuals Aged 60 Years or Older, Mild Cognitive Impairment (MCI)
Effects of Sleep Restriction on Female Soccer Players: Physical Performance, Muscle Damage, Inflammation, and BDNF Levels.
Status: Unknown · 20 participants · University School of Physical Education, Krakow, Poland
Conditions: Sleep, Sleep Restriction
3h of PNE on BDNF and Pain Levels
Status: Unknown · 66 participants · Universidad Autonoma de Madrid
Conditions: Chronic Pain, Musculoskeletal Pain
The Effect of Theta-burst Stimulation on Serum BDNF
Status: Unknown · 60 participants · Taipei City Hospital
Conditions: Gambling Disorder
Effect of Frontal Transcranial Direct Current Stimulation on BDNF in Stroke Patients With Cognitive Impairment
Status: Unknown · 40 participants · The Second Affiliated Hospital of Dalian Medical University
Conditions: Stroke
Adverse event reports (FDA FAERS)
Not applicable: no licensed product contains this peptide, so it is not reported through FAERS. This is an absence of surveillance, not evidence of safety.
Source: ClinicalTrials.gov and openFDA. Updated automatically.
Looking for BDNF?
Source research-grade BDNF from a trusted UK supplier — third-party tested with certificate of analysis.
View at SupplierFrequently Asked Questions
Questions to ask a qualified clinician about BDNF
These are starter questions you can adapt for a GP, specialist, pharmacist, or anti-doping advisor. The aim is to help you have a better-informed conversation — not to replace one.
- What evidence-based interventions affect BDNF (exercise, sleep, licensed medicines)?
Related Peptides
Selank
A synthetic peptide based on tuftsin, developed in Russia for anxiolytic and nootropic properties, approved there for anxiety and neurasthenia.
Learn moreSemax
A synthetic peptide based on ACTH, developed in Russia as a nootropic and neuroprotectant, approved there for cognitive disorders and stroke.
Learn more